AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Atomwise vs DAX Copilot

Atomwise

Atomwise

VS
DAX Copilot

DAX Copilot

Verdict by Category

Detailed category analysis is not available for this comparison.
View Atomwise View DAX Copilot

Detailed Comparison

Feature
Atomwise
DAX Copilot
Pricing
CustomAtomwise operates through enterprise partnership and co-development agreements — there is no self-serve access or published pricing. Collaboration types include: sponsored research agreements (pharma/biotech pays Atomwise to run AI-powered hit discovery campaigns), co-development partnerships (shared IP and milestone/royalty structures), and academic program access for universities through the ATOM initiative. New CEO Steve Worland is also steering Atomwise toward an internal proprietary drug pipeline, which will generate revenue through future licensing and partnering deals as candidates mature into preclinical and clinical stages. Contact Atomwise through atomwise.com for partnership and collaboration inquiries.
CustomMicrosoft does not publish self-serve pricing for DAX Copilot / Dragon Copilot; access is sold through Microsoft sales or authorized Cloud Solution Provider resellers, and pricing has varied significantly by channel and date. For years, authorized resellers commonly quoted $369-$830+ per provider per month plus a one-time setup fee (often around $650-$700), depending on contract size and minimum term. In a May 2026 marketplace restructuring, Microsoft published tiered list pricing including a Flex plan at roughly $604.80 per user per month (base license plus pay-as-you-go ambient use) and a higher uncapped Per-User tier around $1,512 per user per month (itself a 57% cut from a prior list price). A lower-cost "Physician Practice" license aimed at 5-50 clinician offices was briefly offered via the CSP channel at roughly $150-$160 per user per month before reaching end-of-sale on May 1, 2026. Large health systems negotiating volume, multi-year contracts frequently report effective rates well below these list prices. There is no public free trial for individual purchase, though Microsoft runs structured 30-90 day enterprise pilot programs for qualifying health systems.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Summary
Deep learning for structure-based drug discovery — AtomNet screens 16B+ compounds to find hits for any disease target
Microsoft's enterprise ambient AI for physicians, nurses, and radiologists — formerly Nuance DAX
Atomwise

Atomwise Pros & Cons

Pros

  • Invented deep learning for structure-based drug discovery in 2012 — true pioneer in the field
  • AtomNet screens 16B+ compounds in under 2 days — fastest virtual screening at this scale
  • 775+ collaborations and 250+ partners — most validated partnership network in AI drug discovery
  • Tackles undruggable targets that traditional methods can't address
  • Strong academic program: 40+ universities including Harvard, Stanford, and Duke
  • New Foundation Model announced 2026 — next-generation AI for molecular discovery
  • $226M+ raised from DCVC, Khosla, Y Combinator, Tencent, B Capital, and Baidu

Cons

  • Early-stage company — no FDA-approved drugs from the platform yet
  • Shifting focus from platform licensing to proprietary pipeline adds execution risk
  • Smaller team (~100-250 employees) compared to larger AI drug discovery peers
  • Revenue still modest at $5-25M range — pre-commercial stage
  • Deep tech focus means long timelines before patient impact is realized
DAX Copilot

DAX Copilot Pros & Cons

Pros

  • Broadest role coverage of any major ambient AI platform, spanning physicians, nurses, and radiologists in one product family
  • Deepest, longest-running Epic integration in the category, built on two decades of Dragon speech technology
  • Backed by Microsoft's security, compliance (HITRUST, SOC 2 Type II), and Azure infrastructure at massive scale
  • Extensible via a Developer Kit and third-party app marketplace rather than a closed, single-vendor tool
  • Strong, publicly documented customer outcomes (time-in-note reductions, added appointments) across large health systems
  • Available across multiple countries for physicians, with continued regional expansion

Cons

  • No public pricing; buyers must go through Microsoft sales or a reseller, and quoted rates vary enormously (roughly $150 to $1,500+ per provider per month across sources)
  • No self-serve signup or public free trial, unlike most consumer-facing AI scribes; enterprise procurement is required even for small practices
  • Historically the most expensive mainstream ambient scribe, which prices out solo clinicians and small independent practices
  • EHR write-back connectors for non-Epic systems are sometimes a separate, additional cost arranged through third-party partners
  • Nurse and radiologist experiences have more limited geographic availability (US-only, with radiology still in preview) than the physician product